KALV
KalVista Pharmaceuticals, Inc.Company with tickers: KALV
CIK
1348911
CUSIP
483497103
Shares Outstanding
53,240,888
Website
https://www.kalvista.com
Investor Relations
https://www.kalvista.com/investors-news/
13F Activity (30d)
3 filings
2 filers
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-05-27 | CHRISTOPHER M YEA | Officer | 33,800 | 2026-05-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-07-16 | Edward Feener | Former Officer | 13,972 | 2024-07-16 | J.P. Morgan Securities LLC |
| 2024-01-08 | Edward Feener | Officer | 59,891 | 2024-01-08 | J.P. Morgan Securities LLC |
| 2023-12-27 | Andrew Crockett | Officer | 40,000 | 2023-12-27 | J.P. Morgan Securities LLC |
| 2023-09-11 | Cha Albert | Officer | 18,000 | 2023-09-11 | Morgan Stanley Smith Barney LLC Executive Services |
Showing 1–5 of 5 filings